Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 8 studies | 23% ± 5% | |
peripheral blood | 7 studies | 24% ± 9% | |
brain | 6 studies | 26% ± 8% | |
intestine | 4 studies | 24% ± 10% | |
liver | 4 studies | 34% ± 17% | |
pancreas | 3 studies | 32% ± 8% | |
eye | 3 studies | 24% ± 6% | |
uterus | 3 studies | 27% ± 12% | |
breast | 3 studies | 22% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 5418.90 | 1445 / 1445 | 100% | 85.47 | 183 / 183 |
ovary | 100% | 6896.14 | 180 / 180 | 100% | 90.30 | 430 / 430 |
skin | 100% | 6850.57 | 1809 / 1809 | 100% | 114.68 | 472 / 472 |
stomach | 100% | 4211.38 | 359 / 359 | 100% | 91.10 | 286 / 286 |
uterus | 100% | 6417.02 | 170 / 170 | 100% | 109.61 | 459 / 459 |
lung | 100% | 4850.19 | 578 / 578 | 100% | 80.39 | 1153 / 1155 |
intestine | 100% | 5627.16 | 966 / 966 | 100% | 98.24 | 526 / 527 |
breast | 100% | 5375.18 | 459 / 459 | 100% | 81.73 | 1114 / 1118 |
bladder | 100% | 5861.95 | 21 / 21 | 100% | 93.83 | 502 / 504 |
prostate | 100% | 6033.76 | 245 / 245 | 100% | 65.73 | 500 / 502 |
pancreas | 100% | 4171.67 | 328 / 328 | 99% | 55.27 | 177 / 178 |
brain | 99% | 4870.88 | 2626 / 2642 | 100% | 85.37 | 705 / 705 |
thymus | 100% | 5393.30 | 653 / 653 | 99% | 55.52 | 601 / 605 |
adrenal gland | 100% | 4974.95 | 258 / 258 | 97% | 58.07 | 223 / 230 |
kidney | 100% | 4007.67 | 89 / 89 | 96% | 39.22 | 862 / 901 |
liver | 100% | 3054.94 | 225 / 226 | 94% | 40.87 | 382 / 406 |
adipose | 100% | 5887.20 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 81.21 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 126.73 | 29 / 29 |
spleen | 100% | 8484.20 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 97.42 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 55.18 | 1 / 1 |
blood vessel | 100% | 4040.67 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 3762.63 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 2803.21 | 838 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 92% | 4985.15 | 855 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006364 | Biological process | rRNA processing |
GO_0042274 | Biological process | ribosomal small subunit biogenesis |
GO_0005732 | Cellular component | sno(s)RNA-containing ribonucleoprotein complex |
GO_0005730 | Cellular component | nucleolus |
GO_0070761 | Cellular component | pre-snoRNP complex |
GO_0001650 | Cellular component | fibrillar center |
GO_0005654 | Cellular component | nucleoplasm |
GO_0031428 | Cellular component | box C/D methylation guide snoRNP complex |
GO_0032040 | Cellular component | small-subunit processome |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0045296 | Molecular function | cadherin binding |
GO_0030515 | Molecular function | snoRNA binding |
GO_0005515 | Molecular function | protein binding |
GO_1990226 | Molecular function | histone methyltransferase binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | NOP56 |
Protein name | Nucleolar protein 5A Nucleolar protein 56 (Nucleolar protein 5A) NOP56 protein |
Synonyms | NOL5A |
Description | FUNCTION: Involved in the early to middle stages of 60S ribosomal subunit biogenesis. Core component of box C/D small nucleolar ribonucleoprotein (snoRNP) particles. Required for the biogenesis of box C/D snoRNAs such U3, U8 and U14 snoRNAs . Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding, modifications, rearrangements and cleavage as well as targeted degradation of pre-ribosomal RNA by the RNA exosome . . |
Accessions | H0Y653 Q5JXT2 Q9BSN3 H0YDU4 ENST00000467196.5 ENST00000329276.10 ENST00000415272.2 ENST00000651302.1 A0PJ92 O00567 ENST00000445139.1 A0A494C128 |